三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
国内用于治疗ROS1基因重排的ROS1、TRK抑制剂研发进展
国内用于治疗ROS1基因重排的ROS1、TRK抑制剂研发进展
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:146KB
图片尺寸:2268*750
同报告图片
/
4
fCDlhazlj7ggICAgIHwg5Lqn5ZOBICAgICAgICAgICB8IOmdtueCuSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCDpgILlupTnl4cgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwg5Li05bqK6L+b5bqmIHwKfC0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tfAp8IOe9l+awj+WItuiNryB8IOaBqeabsuabv+WwvCAgICAgICB8IEFMSyxOVFJLMixOVFJLMSxOVFJLMyxST1MxLFRSSyAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwg6Z2e5bCP57uG6IOe6IK655mM5Ly0IFJPUzEg5Z+65Zug6YeN5o6S77yI5Ly05oiW5LiN5Ly05Lit5p6i56We57uP57O757uf6L2s56e777yJIHwgSUlJIOacnyAgIHwKfCDokYblhYPljLvoja8gfCBUYWxldHJlY3RpbmliICB8IE5UUksyLE5UUksxLE5UUkszLFJPUzEsVFJLICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgUk9TMSDono3lkIjln7rlm6DpnZ7lsI/nu4bog57ogrrnmYwgICAgICAgICAgICAgICAgICAgICAgIHwgSUkg5pyfICAgIHwKfCDlho3pvI7ljLvoja8gfCDmtJvmma7mm7/lsLwgICAgICAgfCBBTEssTlRSSzIsUFRLMixOVFJLMSxOVFJLMyxST1MxLFNSQyxKQUsyLFBUSyxUUkssVHJvcG9teW9zaW4gICAgICAgICAgfCDmkLrluKYgQUxL44CBUk9TMSDmiJYgTlRSSzEgLSAzIOmHjeaOkueahOaZmuacn+WunuS9k+eYpCAgICAgfCBJSSDmnJ8gICAgfAp8IOe9l+awj+WItuiNryB8IOaBqeabsuabv+WwvCAgICAgICB8IEFMSyxOVFJLMixOVFJLMSxOVFJLMyxST1MxLFRSSyAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwg5pC65bimIE5UUksxLzIvM+OAgVJPUzEg5oiWIEFMSyDln7rlm6Dph43mjpLnqoHlj5jnmoTlrp7kvZPnmKQgfCBJSSDmnJ8gICAgfAp8IOaIkOmDveWFiOWvvCB8IEhHMDMwICAgICAgICAgIHwgUk9TMSxUUksgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCBOVFJLIOaIliBST1MxIOWfuuWboOiejeWQiOaIkOS6uuaZmuacn+WunuS9k+eYpCAgICAgICAgICAgICB8IEkg5pyfICAgICB8Cnwg5YWI5aOw6I2v5LiaIHwgU0lNMTE4MDMgLSAxQSAgfCBST1MxLFRSSyAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IE5UUkvjgIFST1MxIOaIliBBTEsg5Z+65Zug6J6N5ZCI56qB5Y+Y55qE5a6e5L2T55ikICAgICAgICAgIHwgSSDmnJ8gICAgIHwKCui1hOaWmeadpea6kO+8mkluc2lnaHQg5pWw5o2u5bqT77yM5Lit5L+h6K+B5Yi456CU56m26YOo
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
所属报告:
信达生物-投资价值分析报告:快速崛起的国际化Biopharma-210708(60页).pdf
打包全文图表
相关数据
JAK抑制剂在骨髓纤维化治疗中的竞争格局
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
收藏
竞争格局
2026-06-26
原图定位
查看详情
《KAT6抑制剂化合物、药物组合物及其制备方法和N-(6-((1H-pyrazol-1-yl)methyl)-4-metho
fCDnjq9B57uT5p6E57G75Z6LICAgICAgIHwg57uT5p6E56S65L6L5o+P6L+wICAgICAgICAgICAgICAgICAgICAgfAp8LS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IOWQsuWTmuWVieihjeeUn+eJqSAgICAgIHwg6Iuv5bm25YWt5YWD546v5ZCr5rCu5Y6f5a2QICAgICAgICAgICAgICAgfAp8IOWTjOWVtuihjeeUn+eJqSAgICAgICAgfCDlha3lhYPnjq/lkKvmsKjln7rvvIgtTkgt77yJICAgICAgICAgICAgIHwKfCDlkJfllYnooY3nlJ/niakgICAgICAgIHwg5YWt5YWD546v5ZCr5rCn5Y6f5a2Q5ZKM5rCu5Y6f5a2QICAgICAgICAgICB8Cnwg5YWt5rCi5ZCh5ZW26KGN55Sf54mpICAgIHwg5YWt5YWD546v5ZCr5rCu5Y6f5a2QICAgICAgICAgICAgICAgICAgIHwKfCDlkKHlkq/ng7fooY3nlJ/niakgICAgICB8IOS6lOWFg+eOr+WQq+awruWOn+WtkCAgICAgICAgICAgICAgICAgICB8Cnwg5rCu5p2C546v5LiB54O36KGN55Sf54mpICB8IOWbm+WFg+eOr+WQq+awruWOn+WtkCAgICAgICAgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrjgIpLQVQ2IOaKkeWItuWJguWMluWQiOeJqeOAgeiNr+eJqee7hOWQiOeJqeWPiuWFtuWItuWkh+aWueazleWSjOW6lOeUqOOAi++8jOS4reazsOivgeWIuOeglOeptuaJgO+8mw==
收藏
行业数据
2026-05-11
原图定位
查看详情
图10、全球PD-(L)1抑制剂市场规模(十亿美元)
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
收藏
市场规模
2026-05-11
原图定位
查看详情
图10.VMAT2抑制剂全球销售情况(亿美元)
收藏
行业数据
2026-04-20
原图定位
查看详情
全球PCSK9抑制剂市场规模(亿美元)
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
收藏
市场规模
2026-04-13
原图定位
查看详情
中国PCSK9抑制剂市场规模(亿人民币)
收藏
市场规模
2026-04-13
原图定位
查看详情
相较于PD-(L)1抑制剂,PD-(L)1/VEGF双抗有极大替代和拓展空间
收藏
行业数据
2026-03-31
原图定位
查看详情
全球在研FXI/FXIa抑制剂的临床进展
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
收藏
行业数据
2026-02-26
原图定位
查看详情
FXI/FXIa抑制剂全球可触及患者数
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
收藏
行业数据
2026-02-26
原图定位
查看详情
图表11FDA获批KRASG12C抑制剂的全球销售额(百万美元)
收藏
行业数据
2026-02-25
原图定位
查看详情
图表19KRASG12D抑制剂竞争格局
收藏
竞争格局
2026-02-25
原图定位
查看详情
图3 mCRC中EGFR抑制剂的美国收入(2004-2017)
收藏
行业数据
2026-02-13
原图定位
查看详情
主要JAK抑制剂全球销售额
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
收藏
行业数据
2026-01-30
原图定位
查看详情
国内主要JAK抑制剂在研格局
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
收藏
竞争格局
2026-01-30
原图定位
查看详情
JAK抑制剂:国内样本医院销售额
fCDlubTku70gfCDoiqblj6/mm7/lsLzvvIjnmb7kuIflhYPvvIkgfCDmiZjms5Xmm7/luIPvvIjnmb7kuIflhYPvvIkgfCDlt7TnkZ7mm7/lsLzvvIjnmb7kuIflhYPvvIkgfCDkuYzluJXmm7/lsLzvvIjnmb7kuIflhYPvvIkgfCDpmL/luIPmmJTmm7/lsLzvvIjnmb7kuIflhYPvvIkgfCDliKnnibnmmJTmm7/lsLzvvIjnmb7kuIflhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18CnwgMjAxOCB8IDAgICAgICAgICAgICAgICAgICAgfCAwICAgICAgICAgICAgICAgICAgfCAtICAgICAgICAgICAgICAgICAgfCAtICAgICAgICAgICAgICAgICAgfCAtICAgICAgICAgICAgICAgICAgICAgfCAtICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDE5IHwgMiAgICAgICAgICAgICAgICAgICB8IDIgICAgICAgICAgICAgICAgICB8IH40MjAgICAgICAgICAgICAgICB8IC0gICAgICAgICAgICAgICAgICB8IC0gICAgICAgICAgICAgICAgICAgICB8IC0gICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjAgfCA3NiAgICAgICAgICAgICAgICAgIHwgPyAgICAgICAgICAgICAgICAgIHwgfjUyMCAgICAgICAgICAgICAgIHwgLSAgICAgICAgICAgICAgICAgIHwgLSAgICAgICAgICAgICAgICAgICAgIHwgLSAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyMSB8IDE0OSAgICAgICAgICAgICAgICAgfCA/ICAgICAgICAgICAgICAgICAgfCB+MTcwICAgICAgICAgICAgICAgfCA/ICAgICAgICAgICAgICAgICAgfCA/ICAgICAgICAgICAgICAgICAgICAgfCA/ICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDIyIHwgMTU1ICAgICAgICAgICAgICAgICB8ID8gICAgICAgICAgICAgICAgICB8IH4xMjAgICAgICAgICAgICAgICB8ID8gICAgICAgICAgICAgICAgICB8ID8gICAgICAgICAgICAgICAgICAgICB8ID8gICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjMgfCAxODEgICAgICAgICAgICAgICAgIHwgPyAgICAgICAgICAgICAgICAgIHwgfjE0MCAgICAgICAgICAgICAgIHwgPyAgICAgICAgICAgICAgICAgIHwgPyAgICAgICAgICAgICAgICAgICAgIHwgPyAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyNCB8IDIyNyAgICAgICAgICAgICAgICAgfCA/ICAgICAgICAgICAgICAgICAgfCB+MTEwICAgICAgICAgICAgICAgfCA/ICAgICAgICAgICAgICAgICAgfCA/ICAgICAgICAgICAgICAgICAgICAgfCA/ICAgICAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8mlBEQu+8jOWNjuazsOeglOeptg==
收藏
行业数据
2026-01-30
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
II 期临床初步结果表现良好,进度国内领先。目前 Taletrectinib 正在开展三项二期临床试验:1)一线 TKI 初治和二线 TKI 经治 ROS1 阳性 NSCLC(中国开展);2)NTRK阳性实体瘤(中国开展);2)一线和二线 ROS1 阳性 NSCLC(全球开展)。2021 年 ASCO会议Taletrectinib用于ROS1融合阳性NSCLC的二期临床试验初步结果以壁报形式公开。在未经过克唑替尼治疗的患者中(n=15),ORR 为 93%,DCR 为 93%;在曾接受过克唑替尼治疗的患者(n=5),ORR 为 60%,DCR 为 100%,其中 3 例患者 ROS1 G2032R 耐药突变且具有肿瘤缩小表现,在有效性和安全性上均展示出良好结果。目前国内治疗 ROS1基因重排的 ROS1/TRK 抑制剂进展最快的罗氏处于临床 III 期,公司处于临床 II 期,进度位于国内前列。
行业数据
原图定位
当前图表所属:
信达生物-投资价值分析报告:快速崛起的国际化Biopharma-210708(60页).pdf
国内PD-1单抗在霍奇金淋巴瘤适应症上的研发进展
中国市场已获批PD-1/PD-L1单抗产品
经2019年或2020年医保谈判被纳入医保目录的PD-1产品治疗费用情况
2020年国产PD-1单抗销售额及单价对比
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》